Venlafaxine Hcl
Brand name: Venlafaxine Hcl
Rank #214 of 500 drugs by total cost
$64.7M
Total Cost
2,187,710
Total Claims
$64.7M
Total Cost
66,093
Prescribers
$30
Cost per Claim
187,605
Beneficiaries
4,026,256
30-Day Fills
$979
Avg Cost/Provider
33
Avg Claims/Provider
About Venlafaxine Hcl
Venlafaxine Hcl (sold as Venlafaxine Hcl) was prescribed 2,187,710 times by 66,093 Medicare Part D providers in 2023, costing the program $64.7M. At $30 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 211 | Dabigatran Etexilate Mesylate (Dabigatran Etexilate) | $66.0M | 220,652 |
| 212 | Netarsudil Mesylate (Rhopressa) | $65.6M | 129,116 |
| 213 | Risperidone Microspheres (Risperdal Consta) | $64.8M | 47,567 |
| 214 | Venlafaxine Hcl (Venlafaxine Hcl) | $64.7M | 2,187,710 |
| 215 | Canagliflozin (Invokana) | $63.7M | 66,550 |
| 216 | Belimumab (Benlysta) | $63.4M | 13,386 |
| 217 | Collagenase Clostridium Hist. (Santyl) | $63.3M | 70,641 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology